Results 61 to 70 of about 712 (172)

Structure-Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor. [PDF]

Biomol Ther (Seoul), 2023
Wang S, Zhu A, Paudel S, Jang CG, Lee YS, Kim KM.   +5 more
europepmc   +1 more source

An Innovative Integrated Method in MHD Design of Electromagnetic Stirrers

, 2008
Design and optimization of stirrers are complex activities for two main reasons: there is no standard in steelmaking plants, meaning that a personalized design is typically required, and it is not possible to accurately predict the flow induced to liquid
NOBILE, ENRICO, Persi C., SPAGNUL, STEFANO, Battistutto B.   +3 more
core  

A Stereoconvergent Annulation in the Synthesis of Lysergic Acid. [PDF]

Synthesis (Stuttg)
Firestone ZD, Harbit RC, Smith JM.
europepmc   +1 more source

Drugs of abuse

, 2016
\ua9 2016 Elsevier Ltd. All rights reserved.Toxicity related to drug misuse is a common reason for hospital presentation. The recent emergence of substantial numbers of novel psychoactive substances has made management more challenging because the exact ...
Thomas SHL, Hill SL
core   +1 more source

Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α‑Arylation, Borrowing Hydrogen Alkylation, and C–H Insertion

Lysergic acid diethylamide (LSD), a semisynthetic ergoline alkaloid analogue and hallucinogen, is a potent psychoplastogen with promising therapeutic potential.
Lee E. Dunlap (5135045), David E. Olson (1987003), Jeremy R. Tuck (10844876)   +2 more
core   +1 more source

Novel Ergolines as 5‑HT2A Agonists for Treating Mood Disorders. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

ChemInform Abstract: Electrochemical Oxidation of Ergolines.

, 1992
K. SEIFERT, B. R. VINCENT, NGUYEN MINH PHUONG NGUYEN MINH PHUONG   +2 more
core   +1 more source

Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. [PDF]

Front Psychiatry
Williams ML, Rudin D, Schmid Y, von Salm J.   +3 more
europepmc   +1 more source

The structural diversity of psychedelic drug actions revealed. [PDF]

Nat Commun
Gumpper RH, Jain MK, Kim K, Sun R, Sun N, Xu Z, DiBerto JF, Krumm BE, Kapolka NJ, Kaniskan HÜ, Nichols DE, Jin J, Fay JF, Roth BL.   +13 more
europepmc   +1 more source